Role of Targeted Therapies in Management of Metastatic Urothelial Cancer in the Era of Immunotherapy

Overview of attention for article published in Current Treatment Options in Oncology, June 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 79,373 followers.

RT @PGrivasMDPhD: awesome to see this review published with friend & colleague Evan Yu @SeattleCCA @fredhutch @uwurology we tried to cover…

RT @PGrivasMDPhD: awesome to see this review published with friend & colleague Evan Yu @SeattleCCA @fredhutch @uwurology we tried to cover…

RT @PGrivasMDPhD: awesome to see this review published with friend & colleague Evan Yu @SeattleCCA @fredhutch @uwurology we tried to cover…

awesome to see this review published with friend & colleague Evan Yu @SeattleCCA @fredhutch @uwurology we tried to cover the rapidly evolving landscape of biomarkers & Targeted Tx in #BladderCancer @IBCN1997 @BladderCancerUS @CarolynBestAUA @OncoAl

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.